SecBot SecBot
144 ·Filed Oct 30, 2026

REGN

REGENERON PHARMACEUTICALS, INC.
NEUTRAL
Impact 2/10
Horizonimmediate Processed17d 7h ago SEC0001969223-26-001108
Form 144: notice of proposed sale of securities
Actionable Insight • Neutral

The Form 144 signals an officer's intent to sell a small number of shares from vested RSUs, consistent with routine tax-related or diversification selling. The prior sales in September 2026 suggest a pattern of periodic dispositions. No material impact on the stock is expected.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5
Entry
$961.26
T+0 close · Oct 30, 2026 · via day close
Latest settled
−4.30%
T+5 · $919.96 · next T+20 in 14d
Vs SPY
−4.37%
α at T+5
Latest observation
−0.14%
T+9 · FF3 residual α
  1. T+0 · Nov 2 $961.26entry
  2. T+1 · 14d ago +1.26%α +0.96% · $973.36
  3. T+5 · 8d ago −4.30%α −4.37% · $919.96
  4. T+10 · todayOpen
  5. T+20 · in 14d Pending
  6. T+60 · in 2mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Marion McCourt, an officer of Regeneron Pharmaceuticals, filed a Form 144 notice of intent to sell 1,132 shares of common stock, valued at approximately $984,195 based on the filing date price. The shares were acquired via restricted stock award vesting in December 2023. This is a routine insider sale notice representing a small fraction of the company's $83.7B market cap.

Key Facts

  • Marion McCourt, an officer of Regeneron, filed Form 144 to sell 1,132 shares of common stock.
  • Estimated sale value is approximately $984,195 based on the filing date price of ~$869 per share.
  • Shares were acquired on 12/12/2023 via restricted stock award vesting from the issuer.
  • The sale is proposed to occur on or after 10/30/2026 on Nasdaq.
  • The filing also notes two prior sales by McCourt in September 2026: 1,215 shares on 09/02/2026 and 1,131 shares on 09/03/2026.
  • The proposed sale represents about 0.001% of Regeneron's $83.7B market cap.

Financial Impact

Proposed sale of 1,132 shares valued at ~$984,195, negligible relative to $83.7B market cap.

dilution

Risk Factors

  • Insider selling could increase if additional officers file similar notices, but this single filing is immaterial.
  • The sale may not occur; Form 144 is an intent notice, not a completed transaction.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
70% bullish (37 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001969223-26-001108
Document: 0001969223-26-001108-index.html0001969223-26-001108
Document: 0001969223-26-001108.txt0001969223-26-001108

Track record

53 reports on REGN

Performance horizon

11 of 17 bullish or bearish reports moved the stock their way by T+20. Best: +31.76% at T+20 after the Oct 6, 2026 report. 17 of 21 went positive at some point.

Filters
  1. Nov 16, 2026today 144 Neutral 2/10 Entry $951.23 Now $952.40 +0.12% settles Dec 16
  2. Nov 16, 2026today 144 Neutral 2/10 Entry $948.00 Now $952.40 +0.46% settles Dec 16
  3. Nov 12, 20264d ago Press Release Bullish 5/10 Entry $955.47 Now $952.40 −0.32% settles Dec 14
  4. Nov 5, 202611d ago Insider Cluster Neutral 2/10 Entry $904.35 Now $952.40 +5.31% settles Dec 7
  5. Nov 5, 202611d ago Insider Cluster Neutral 3/10 Entry $904.35 Now $952.40 +5.31% settles Dec 7
  6. Nov 4, 202612d ago 144 Neutral 1/10 Entry $902.90 Now $952.40 +5.48% settles Dec 4
  7. Nov 4, 202612d ago 144 Neutral 2/10 Entry $902.90 Now $952.40 +5.48% settles Dec 4
  8. Nov 3, 202613d ago Insider Cluster Neutral 2/10 Entry $930.67 Now $952.40 +2.33% settles Dec 3
  9. Nov 3, 202613d ago 144 Neutral 2/10 Entry $930.67 Now $952.40 +2.33% settles Dec 3
  10. Nov 3, 202613d ago Insider Cluster Neutral 2/10 Entry $930.67 Now $952.40 +2.33% settles Dec 3
Showing 10 of 53

US Market Status

Market Closed · Opens Wed (10h 26m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 30, 2026